VI-0609

N/A

Report date: 2024/01/24 16:08:57

Base Information

Drug NameVI-0609
Drug Alias NameVI-0609
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsBone marrow transplant rejectionLymphoma, Non-HodgkinHodgkin Disease +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesVivus Inc
China Registration ClassN/A

Develop Information

Active CompaniesVivus LLCVivus Inc
Inactive CompaniesN/A
Active IndicationsBone marrow transplant rejectionLymphoma, Non-HodgkinHodgkin Disease +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A